EN
HI
Summary
As of 3 Nov, 2026, Alembic Pharmaceuticals stock price is ₹803. During the trading session, the stock has moved between an intraday low of ₹786.50 and an intraday high of ₹806.70. Over the last 52 weeks, Alembic Pharmaceuticals has traded between ₹635.80 and ₹998.00.
The stock has recorded a trading volume of 97,135 shares,. Its Average Traded Price (ATP) is ₹795.94, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹803.00.
Alembic Pharmaceuticals has an upper circuit limit of ₹957.40 and a lower circuit limit of ₹638.30. The total value traded stands at ₹7.73 CR, and the delivery percentage for the day is 69.42%.
The stock is currently traded with a market lot size of 1. Alembic Pharmaceuticals also offers a dividend yield of 1.5%.
Alembic Pharmaceuticals Share Price Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
97135.00
Market Cap
15784.02 CR
LTQ@LTP
25@803.00
ATP
795.94
Var Margin
15.12 %
Circuit Range
638.3-957.4
Delivery %
69.42 %
Value
7.73 CR
ASM/GSM
No
Market Lot
1
Alembic Pharmaceuticals Fundamentals
P/E Ratio
22.61
P/B Ratio
2.68
Div. Yield
1.5
Sector P/E
39.15
Sector P/B
3.23
Sec. Div. Yield
0.54
Alembic Pharmaceuticals Resistance and Support
Pivot 793.97
Resistance
First Resistance
803.89
Second Resistance
809.92
Third Resistance
819.84
Support
First Support
787.94
Second Support
778.02
Third Support
771.99
Alembic Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 02 2026 | 801.1 | 803 | 0.65% | 806.7 | 786.5 |
| Fri Oct 30 2026 | 794.84 | 797.84 | 0.38% | 800 | 784.04 |
| Thu Oct 29 2026 | 780.4 | 794.84 | 1.54% | 801 | 776 |
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-04 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2026.
Alembic Pharmaceuticals has scheduled a board meeting on 4 November 2026. The primary agenda is to approve the financial results for the quarter and half year ended 30 September 2026.
Oct 28 2026 15:27:40
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals has received USFDA final approval for its Abbreviated New Drug Application (ANDA) for Valganciclovir for Oral Solution, 50 mg/mL. The approved product is therapeutically equivalent to Valcyte by CHEPLAPHARM, bringing the company's total ANDA approvals to 247.
Oct 27 2026 15:29:15
Read More
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Shilpa Medicare Ltd.
924.55
-31.05 (3.25%)
Caplin Point Laboratories Ltd.
2336.40
10.80 (0.46%)
Onesource Specialty Pharma Ltd.
1558.20
-4.80 (0.31%)
Pfizer Ltd.
3638.70
-49.10 (1.33%)
Eris Lifesciences Ltd.
1160.20
3.80 (0.33%)
Dr. Agarwal's Health Care Ltd.
513.85
4.65 (0.91%)
Natco Pharma Ltd.
785.75
3.35 (0.43%)
Vijaya Diagnostic Centre Ltd.
1457.40
11.70 (0.81%)
Molbio Diagnostics Ltd.
1314.10
40.10 (3.15%)
Jubilant Pharmova Ltd.
946.75
22.95 (2.48%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 803 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 22.61. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.68. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.15 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 15784.02 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 998.00 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in APLLTD
